TIL Antibody

Definition and Biological Context

"TIL antibodies" refer to therapeutic or research-grade antibodies used to modulate, enhance, or study tumor-infiltrating lymphocytes (TILs)—immune cells that naturally migrate into tumors. These antibodies are not standalone compounds but tools to augment TIL function, persistence, or specificity in cancer immunotherapy. Key applications include:

• Checkpoint inhibitors (e.g., anti-PD-1, anti-CTLA-4) to counteract TIL exhaustion .

• Cytokines (e.g., IL-2) to support TIL expansion and activity .

• Targeted antibodies (e.g., anti-LAG3) to block inhibitory pathways in the tumor microenvironment .

Mechanisms of Action in TIL Therapy

Antibodies are integrated into TIL therapy protocols to overcome immunosuppression and amplify antitumor responses:

Melanoma (Most Studied Indication)

• Lifileucel (FDA-approved TIL therapy):

  • ORR: 31.4% (153 patients), with 5.2% complete responses (CR) .

  • 4-year survival rate: 49% in responders .

• Combination with anti-PD-1:

  • ORR rises to 58% in anti-PD-1-refractory melanoma .

Non-Melanoma Solid Tumors

Biomarkers and Antibody Synergy

• CD8+/FoxP3+ TIL ratio: Higher ratios correlate with prolonged survival (HR 0.48, 95% CI 0.34–0.68) .

• Telomere length in TILs: Longer telomeres predict durable responses (median OS: 21.3 vs. 9.1 months) .

• Prior anti-PD-1 exposure: No significant difference in TIL efficacy (pooled ORR 34% vs. 44%) .

Challenges and Innovations

• Limitations:

  • Low TIL reactivity in "cold" tumors (e.g., gastrointestinal cancers) .

  • High manufacturing costs (~$150,000 per patient) .

• Emerging Solutions:

  • CRISPR-engineered TILs: Knockout of PD-1 or TGF-β receptors to resist suppression .

  • Neoantigen-specific TILs: 82.6% of gastrointestinal TILs show neoantigen reactivity in preclinical studies .

Future Directions

• Phase III trials for cervical and lung cancers (NCT04611126, NCT05292884) .

• Cost-reduction strategies: Automated TIL expansion systems cut production time from 6 to 3 weeks .